Kardigan, Inc.
- Last sale
- Nov 12, 2026 · -10.12%
- Market cap
- $1.32B
- 93.6M shares
- Filings
- 57
Q3 2026
—Q3 2026
—Q3 2026
—Q3 2026derived
—Q3 2026
—Q3 2026+118.8% FY25 yoy
- $1.32B
- —
- —
- 2.3×
- —
- —
FY2026 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
No annual history for this metric yet.
| Period | Ended | Value | Kind | Source trail |
|---|
Pharmaceutical preparations
Kardigan, Inc. is the 130th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
DMRADamora Therapeutics, Inc.———$1.4BAVLNAvalyn Pharma Inc.———$1.4BINVAInnoviva, Inc.$411.3M14.7%65.9%$1.3BOMEROmeros Corp———$1.3BMNKDMannkind Corp$349.0M22.2%1.7%$1.3B
KARDKardigan, Inc. (this company)———$1.3B
URGNUroGen Pharma Ltd.$109.8M21.4%139.8%$1.3BCMPSCOMPASS Pathways plc———$1.3BNKTRNektar Therapeutics$55.2M43.9%297.1%$1.3BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Kardigan, Inc. · CIK 2123613 · Engraved from SEC EDGAR